CHRISTA RUSH: Open Payments
NPI 1760539175 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 28 payments from 19 companies in 2025. Trend: 2023 $836 · 2024 $704 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $113 |
| PFIZER INC. | 3 | $59 |
| Janssen Biotech, Inc. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Eisai Inc. | 2 | $46 |
| JAZZ PHARMACEUTICALS INC. | 1 | $40 |
| Caris MPI, Inc. | 1 | $35 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
Products named: Enhertu, LYNPARZA, Lenvima, ZEPZELCA, MI CANCER SEEK, KEYTRUDA, Nubeqa, XPOVIO.
Industry payments across GA — which companies pay providers there.
